Saturday, September 24, 2022
    HomeHealthWyden wants details on Amgen's U.S. taxes as part of expanding probe...

    Wyden wants details on Amgen’s U.S. taxes as part of expanding probe into pharma practices


    The head of the U.S. Senate Finance Committee is searching for particulars from Amgen in regards to the taxes paid throughout a current four-year interval as a part of an ongoing investigation into tax practices by multinational pharmaceutical firms and efforts made to keep away from paying U.S. taxes.

    Since early final 12 months, Sen. Ron Wyden (D-Ore.), who chairs the committee, has probed the extent to which some firms have allegedly used offshore subsidiaries to keep away from paying U.S. taxes on gross sales. In at the least one occasion, he’s additionally inspecting how an organization might register patents in low-tax jurisdictions to keep away from paying U.S. taxes. Amongst his targets: Merck, Abbott Laboratories, Bristol Myers Squibb, and AbbVie.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!


    Source link

    Related articles

    Stay Connected


    Latest posts